1180594

GSK LLC (GlaxoSmithKline) — FEI 3006810568

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 12, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)